Terms: = Leukemia AND ZNF198, Q9UBW7, SCLL, RAMP, MYM, FIM, 7750 AND Clinical Outcome
1 results:
1. Use of total and unbound imatinib and metabolite LC-MS/MS assay to understand individual responses in CML and GIST patients.
Streit F; Binder L; Hafke A; Brandhorst G; Braulke F; Haase D; Armbrust T; Cameron S; Ramadori G; Oellerich M; Walson P
Ther Drug Monit; 2011 Oct; 33(5):632-43. PubMed ID: 21912334
[TBL] [Abstract] [Full Text] [Related]
